bioMérieux Recognized as Top 1% by S&P Global
March 27, 2025
bioMérieux is honored to be recognized in the top 1% of the S&P Global Sustainability Yearbook 2025, achieving a score of 70/100 in the Health Care Equipment & Supply segment. Out of 7,690 assessed companies across 62 industries, only 780 top performers have received this distinction, highlighting their excellence in sustainable business practices.
Furthermore, bioMérieux was ranked 1st in the sector of healthcare equipment and Supply by the Dow Jones Sustainability Index (DJSI) through the S&P Global Corporate Sustainability Assessment. bioMérieux first joined the DJSI in 2021 and has proudly risen to the top position in just four years! This recognition underscores the company’s strong commitment to Corporate Social Responsibility, reinforcing its mission to create a positive impact worldwide while preserving the planet as a healthy place to live.
Recent News
- Halia Therapeutics Completes Enrollment in Phase 2a Clinical Trial of HT-6184 for Myelodysplastic Syndrome (MDS)
- Myriad Genetics Announces Early Access to the FirstGene Multiple Prenatal Screen
- Growing collaboration with New York Kidney & Hypertension Medicine
- CancerVax Scientists Featured on Cytiva’s “Discovery Matters” Podcast Discussing Universal Cancer Vaccine Platform
- Myriad Genetics Highlights New Research Advancements and Oncology Innovations at 2025 ASCO Annual Meeting
- BD to Initiate Real-World Patient Data Registry for the Rotarex™ Atherectomy System in Treatment of Peripheral Artery Disease
